(Q42703703)

5 November 2017

title

Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism (English)

1 reference

5 November 2017

1 reference

1 reference

1 reference

1

Agrawal S

1 reference

5 November 2017

2

Dixit A

1 reference

5 November 2017

3

Singh A

1 reference

5 November 2017

4

Tripathi P

1 reference

5 November 2017

5

Singh D

1 reference

5 November 2017

6

Patel DK

1 reference

5 November 2017

Mahendra Pratap Singh

series ordinal

7

object named as

Singh MP

1 reference

5 November 2017

language of work or name

English

0 references

publication date

5 November 2014

1 reference

5 November 2017

published in

Molecular Neurobiology

1 reference

5 November 2017

volume

52

1 reference

5 November 2017

issue

3

1 reference

5 November 2017

page(s)

1619-1628

1 reference

Aberrant autophagy and parkinsonism: does correction rescue from disease progression?

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Alpha-synuclein: normal function and role in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

A current review of cypermethrin-induced neurotoxicity and nigrostriatal dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Cypermethrin-induced nigrostriatal dopaminergic neurodegeneration alters the mitochondrial function: a proteomics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Differential up-regulation of striatal dopamine transporter and α-synuclein by the pyrethroid insecticide permethrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Oxidative and nitrative protein modifications in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Neuroprotective effects of Tacrolimus (FK-506) and Cyclosporin (CsA) in oxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Cypermethrin alters the expression profile of mRNAs in the adult rat striatum: a putative mechanism of postnatal pre-exposure followed by adulthood re-exposure-enhanced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

A highly reproducible rotenone model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Cellular and molecular mechanisms of antioxidants in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Cyclosporine A attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Attenuation of zinc-induced intracellular dysfunction and neurotoxicity by a synthetic superoxide dismutase/catalase mimetic, in cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Time-dependant protective effects of mangenese(III) tetrakis (1-methyl-4-pyridyl) porphyrin on mitochondrial function following renal ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Neuroprotective effect of Cyclosporin A on the development of early brain injury in a subarachnoid hemorrhage model: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8954-8

Differential involvement of mitochondrial permeability transition in cytotoxicity of 1-methyl-4-phenylpyridinium and 6-hydroxydopamine

21 January 2018

1 reference

12 December 2020

Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.

1 reference

12 December 2020

10.1007/S12035-014-8954-8

Identifiers

DOI

1 reference

Dimensions Publication ID

5 November 2017

1043324614

0 references

1 reference